Predictors of Outcome in Patients with Pulmonary Hypertension Undergoing Mitral and Tricuspid Valve Surgery

Background and Objectives: Pulmonary hypertension (PH) secondary to left-sided valvular heart disease is associated with poor cardiac surgical outcome compared with patients without PH. Our objective was to investigate the prognostic factors of surgical outcome in patients with PH undergoing mitral valve (MV) and tricuspid valve (TV) surgery, in order to risk stratify their management. Materials and Methods: This is a retrospective observational study on patients with PH who underwent MV and TV surgery from 2011 to 2019. The primary outcome was all-cause mortality. The secondary outcomes were post-op respiratory and renal complications, length of intensive care unit stay and length of hospital stay. Results: Seventy-six patients were included in this study. The all-cause mortality was 13% (n = 10), with mean survival of 92.6 months. Among the patients, 9.2% (n = 7) had post-op renal failure requiring renal replacement therapy and 6.6% (n = 5) had post-op respiratory failure requiring intubation. Univariate analysis demonstrated that pre-operative left ventricular ejection fraction (LVEF), peak systolic tissue velocity at the tricuspid annulus (S’) and etiology of MV disease were associated with respiratory and renal failure. Tricuspid annular plane systolic excursion (TAPSE) was associated with respiratory failure only. S’, type of operation, LVEF, urgency of surgery, and etiology of MV disease were found to be predictive of mortality. After excluding redo mitral surgery, all statistically significant findings remain unchanged, with the addition of right ventricular (RV) size being associated with respiratory failure. In the subgroup analysis of routine cases (n = 56), patients with primary mitral regurgitation who underwent mitral valve repair had better survival outcome. Conclusions: Urgency of surgery, etiology of MV disease, type of operation (replacement or repair), S’ and pre-op LVEF are prognostic indicators in this small cohort of patients with PH undergoing MV and TV surgery. A larger prospective study is warranted to validate our findings.

[1]  M. Mack,et al.  2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.

[2]  P. Lancellotti,et al.  Pulmonary Hypertension with Valvular Heart Disease: When to Treat the Valve Disease and When to Treat the Pulmonary Hypertension , 2019, Current Cardiology Reports.

[3]  Haibo Zhang,et al.  Repair versus replacement of mitral valves in cases of severe rheumatic mitral stenosis: mid-term clinical outcomes. , 2019, Journal of thoracic disease.

[4]  C. Chao,et al.  Prognosis of patients with acute respiratory failure and prolonged intensive care unit stay. , 2019, Journal of thoracic disease.

[5]  F. de Lange,et al.  Impaired right ventricular ejection fraction after cardiac surgery is associated with a complicated ICU stay , 2018, Journal of Intensive Care.

[6]  M. Mourad,et al.  Dobutamine and Nitroglycerin Versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery. A Randomized Controlled Study. , 2018, Journal of cardiothoracic and vascular anesthesia.

[7]  F. Fernández‐Avilés,et al.  Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial , 2017, European heart journal.

[8]  A. Pathak,et al.  Preoperative right ventricular dysfunction is a strong predictor of 3 years survival after cardiac surgery , 2017, Clinical Research in Cardiology.

[9]  M. Enriquez-Sarano,et al.  Twenty-Year Outcome After Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation: Analysis of a Large, Prospective, Multicenter, International Registry , 2017, Circulation.

[10]  B. Westerhof,et al.  The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension. , 2017, Journal of the American College of Cardiology.

[11]  J. Zamorano,et al.  Predictors of persistent pulmonary hypertension after mitral valve replacement , 2016, Heart and Vessels.

[12]  R. D. de Boer,et al.  Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial. , 2015, European heart journal.

[13]  Tezcan Ozrazgat-Baslanti,et al.  Cost and Mortality Associated With Postoperative Acute Kidney Injury. , 2015, Annals of surgery.

[14]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[15]  G. Ailawadi,et al.  Does the Society of Thoracic Surgeons risk score accurately predict operative mortality for patients with pulmonary hypertension? , 2013, The Journal of thoracic and cardiovascular surgery.

[16]  H. Ghofrani,et al.  Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction: A Phase IIb Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Hemodynamic Study , 2013, Circulation.

[17]  Jennifer Taylor,et al.  ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.

[18]  J. Chambers,et al.  Echocardiographic assessment of pulmonary hypertension: standard operating procedure , 2012, European Respiratory Review.

[19]  S. Markwell,et al.  Meta-analysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  M. Enriquez-Sarano,et al.  Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. , 2011, European heart journal.

[21]  Sean M. O'Brien,et al.  Predictors of mitral valve repair: clinical and surgeon factors. , 2010, The Annals of thoracic surgery.

[22]  C. Bauters,et al.  Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation , 2010, Heart.

[23]  Sean M. O'Brien,et al.  Influence of Hospital Procedural Volume on Care Process and Mortality for Patients Undergoing Elective Surgery for Mitral Regurgitation , 2007, Circulation.

[24]  M. Borger,et al.  Predictors of Low Cardiac Output Syndrome After Isolated Aortic Valve Surgery , 2005, Circulation.

[25]  J. Otterstad,et al.  Measuring left ventricular volume and ejection fraction with the biplane Simpson’s method , 2002, Heart.

[26]  T. Fujita,et al.  Organ failures due to low cardiac output syndrome following open heart surgery. , 1986, Japanese circulation journal.

[27]  T. Sundt,et al.  Surgery is Not Associated with Improved Survival Compared to Medical Therapy in Isolated Severe Tricuspid Regurgitation. , 2019, Journal of the American College of Cardiology.

[28]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[29]  P. Sengupta,et al.  Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. , 2015, JACC. Cardiovascular imaging.